Statement | Responders | Evidence level | Consensus |
---|---|---|---|
Any patients affected by CLN2 should be fed according to his/her CNS grade of integrity, or there is no evidence to support feeding CLN2 patients different to any other patient affected by a neurodegenerative disease | 38 | D | 86 |
For CLN2 patients over age 16Â years with significant dysphagia, enteral tube feeding should be considered according to current NICE guidance: https://www.nice.org.uk/guidance/cg32/chapter/1-Guidance#enteral-tube-feeding-in-hospital-and-the-community | 35 | NA | 83 |
Tube feeding should be considered if one of the following is present: Increased risk of choking, Inability to meet nutritional requirements, Confirmed silent aspiration on video fluoroscopy, Repeated episodes of aspiration pneumonia confirmed by imaging | 40 | NA | 94 |